Ling Xu

15PUBLICATIONS
46CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 15, 2026
Proteomics in Antitumor Drug Target Discovery, Toxicity, Resistance, and Precision Oncology.

|Jun 22, 2026
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia.

|Jan 18, 2024
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway.

Xibao Yu, Yan Wang, Jiaxiong Tan

|Jan 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.

Yuchen Li, Yinfeng Gu, Pengyue Yang

|Sep 05, 2023
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

|Nov 25, 2022
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.

Cunte Chen, Siyang Maggie Liu, Yedan Chen

Pageof 3

Frequent Collaborators

14 joint publications

Yangqiu Li

4 joint publications

Zhenyi Jin

4 joint publications

Shaohua Chen

4 joint publications

Yikai Zhang